MDA Research Grants

MDA Research Grants is sponsored by Muscular Dystrophy Association (MDA). The Muscular Dystrophy Association (MDA) awards research grants to scientists investigating promising theories and therapies to accelerate treatments and cures for families living with muscular dystrophy, ALS, and related neuromuscular diseases.

Recent awards have supported projects investigating skeletal muscle-mediated non-cell autonomous neurodegeneration, the role of mitochondrial fusion in myopathy, and the ECM-macrophage axis in muscular dystrophy.

Research Grants | Muscular Dystrophy Association Apply for MDA's Durable Medical Equipment Grant Program Science That Changes Lives From breakthroughs in the lab to real-world progress—accelerating research that delivers results for families today. MDA is committed to transforming the lives of people affected by muscular dystrophy, ALS and related neuromuscular diseases. We do this through innovations in science and innovations in care.

As the largest source of funding for neuromuscular disease research outside of the federal government, MDA has committed more than $1 billion since our inception to accelerate the discovery of therapies and cures. Research we have supported is directly linked to life-changing therapies across multiple neuromuscular diseases.

In addition to the work MDA does to provide the best clinical care and support to families living with neuromuscular disease, funding the most promising and innovative research is a top priority. As the leader in neuromuscular disease research, MDA is more committed than ever to finding treatments and cures.

Our scientific program seeks to: Support research at pivotal stages in development — from research into disease etiology and pathogenesis through to clinical trials. Concentrate research funding on projects which focus on therapy development or tackle key barriers to therapy development. Foster talented new investigators.

Encourage companies to engage in neuromuscular disease research and drug development. Use an intentional and proactive approach to funding research. Leverage MDA’s MOVR Data Hub to accelerate drug development, increase our understanding of neuromuscular diseases, and advance care.

Facilitate collaboration among researchers, and support professional and educational opportunities. Meet Our Current Researchers MDA is the nation’s largest nonprofit supporter of neuromuscular research encompassing over 40 different neuromuscular diseases for 75 years.

With more than $1 billion invested in research since MDA’s inception in 1950, we have contributed to many major advances in muscle biology and therapy development over the decades. To receive updates and alerts about grant opportunities and deadlines, please email grants@mdausa. org to be added to our mailing list.

Clinical Research Awareness Program Clinician Industry Update Webinars Considerations in Care Case Studies MDA Monthly Report - Past Issues and Articles What's New in Neuromuscular Disease Webinars Peer-to-Peer Educational Slide Sets MDA Grants Review Process Research Advisory Committee Pharmacokinetics & Pharmacodynamics MOVR: Neuromuscular Observational Research MOVR 2.

0: The Next Chapter Frequently Asked Questions Newborn Screening for Neuromuscular Diseases Cost of Illness of Neuromuscular Diseases in the US A scientist looking into a microsope " class="img-responsive" /> A helpful looking scientist in a white lab coat " class="img-responsive" /> Muscular Dystrophy Association, Inc. 800-572-1717 | ResourceCenter@mdausa.

org The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization.